Patents by Inventor Timothy Andrew Stewart

Timothy Andrew Stewart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • KETOCONAZOLE ENANTIOMER IN HUMANS
    Publication number: 20190209555
    Abstract: Treatment of patients with the 2S, 4R ketoconazole enantiomer or its pharmaceutically acceptable salts, and solvates is useful for reducing systemic inflammation and cholesterol levels and improving glycemic control.
    Type: Application
    Filed: March 13, 2019
    Publication date: July 11, 2019
    Inventor: Timothy Andrew Stewart
  • KETOCONAZOLE ENANTIOMER IN HUMANS
    Publication number: 20180125841
    Abstract: Treatment of patients with the 2S,4R ketoconazole enantiomer or its pharmaceutically acceptable salts, and solvates is useful for reducing systemic inflammation and cholesterol levels and improving glycemic control.
    Type: Application
    Filed: January 9, 2018
    Publication date: May 10, 2018
    Inventor: Timothy Andrew Stewart
  • KETOCONAZOLE ENANTIOMER IN HUMANS
    Publication number: 20160067243
    Abstract: Treatment of patients with the 2S,4R ketoconazole enantiomer or its pharmaceutically acceptable salts, and solvates is useful for reducing systemic inflammation and cholesterol levels and improving glycemic control.
    Type: Application
    Filed: November 18, 2015
    Publication date: March 10, 2016
    Inventor: Timothy Andrew Stewart
  • Ketoconazole enantiomer in humans
    Patent number: 9198906
    Abstract: Treatment of patients with the 2S,4R ketoconazole enantiomer or its pharmaceutically acceptable salts, hydrates, and solvates is useful for reducing systemic inflammation and cholesterol levels and improving glycemic control.
    Type: Grant
    Filed: October 2, 2007
    Date of Patent: December 1, 2015
    Assignee: Cortendo AB (publ)
    Inventor: Timothy Andrew Stewart
  • Methods and Compositions for Treating Prostate Cancer, Benign Prostatic Hypertrophy, Polycystic Ovary Syndrome and Other Conditions
    Publication number: 20100280046
    Abstract: Pharmaceutical compositions comprising the 2S,4R ketoconazole enantiomer or its pharmaceutically acceptable salts, hydrates, and solvates, that are substantially free of the 2R,4S ketoconazole enantiomer are useful to reduce testosterone synthesis and for the treatment of prostate cancer, benign prostatic hyperplasia, seborrhea, hirsutism, alopecia, polycystic ovary syndrome, and other diseases and conditions, including but not limited to systemic hyperandrogenism.
    Type: Application
    Filed: January 9, 2007
    Publication date: November 4, 2010
    Applicant: DIOBEX, INC.
    Inventor: Timothy Andrew Stewart
  • Ketoconazole Enantiomer in Humans
    Publication number: 20100093755
    Abstract: Treatment of patients with the 2S,4R ketoconazole enantiomer or its pharmaceutically acceptable salts, and solvates is useful for reducing systemic inflammation and cholesterol levels and improving glycemic control.
    Type: Application
    Filed: October 2, 2007
    Publication date: April 15, 2010
    Applicant: CORTENDO INVEST AB,
    Inventor: Timothy Andrew Stewart
  • Methods and Compositions for Treating Barth Syndrome, Cardiomyopathy, Mitochondrial Diseases and Other Conditions
    Publication number: 20090298848
    Abstract: Pharmaceutical compositions comprising the 2S,4R ketoconazole enantiomer or its pharmaceutically acceptable salts, hydrates, and solvates are useful to increase cardiolipin synthesis and for the treatment of Barth Syndrome, diabetic myopathy, cardiomyopathy associated with aging, mitochondrial disease, and other conditions and disorders where cardiolipin deficiency plays a causative or symptomatic role.
    Type: Application
    Filed: April 18, 2007
    Publication date: December 3, 2009
    Applicant: CORTENDO INVEST AB,
    Inventor: Timothy Andrew Stewart